Immune checkpoint inhibitor in microsatellite stable, POLE-mutated, tumor mutational burden-high metastatic colon cancer—a case report
AME Medical Journal · 2026-03 · 11 · 10-10
DOI: 10.21037/amj-24-13 ↗Kurz gefasst
Fallbericht in der Zeitschrift AME Medical Journal, 2026-03. Verfasst von Joseph Zimmerman und 11 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zimmerman, J., Paquette, I., Snyder, J., Wahab, S., Hinrichs, B., Wilson, G., Patel, S., Ahmad, S. A., Latif, T., Kharofa, J., Sohal, D., & Olowokure, O. (2026). Immune checkpoint inhibitor in microsatellite stable, POLE-mutated, tumor mutational burden-high metastatic colon cancer—a case report. AME Medical Journal, 11, 10-10. https://doi.org/10.21037/amj-24-13
Vancouver
Zimmerman J, Paquette I, Snyder J, Wahab S, Hinrichs B, Wilson G, et al. Immune checkpoint inhibitor in microsatellite stable, POLE-mutated, tumor mutational burden-high metastatic colon cancer—a case report. AME Medical Journal. 2026;11:10-10. doi:10.21037/amj-24-13
BibTeX
@article{Zimmerman2026,
author = {Zimmerman, Joseph and Paquette, Ian and Snyder, Jonathan and Wahab, Shaun and Hinrichs, Benjamin and Wilson, Gregory and Patel, Sameer and Ahmad, Syed A. and Latif, Tahir and Kharofa, Jordan and Sohal, Davendra and Olowokure, Olugbenga},
title = {Immune checkpoint inhibitor in microsatellite stable, POLE-mutated, tumor mutational burden-high metastatic colon cancer—a case report},
journal = {AME Medical Journal},
year = {2026},
volume = {11},
pages = {10--10},
doi = {10.21037/amj-24-13}
}
EUVIMED